Clinical Trial Update: CIRSE Registry for SIR-Spheres in France (CIRT-FR)

View source ↗

Summary

A completed CIRSE registry in France evaluating SIR-Spheres Y-90 resin microspheres for liver cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• SIR-Spheres (yttrium-90 glass microspheres)

Snippet

Sponsor: Cardiovascular and Interventional Radiological Society of Europe | Conditions: Liver Cancer | Status: COMPLETED